MIM
GH icon

MetLife Investment Management’s Guardant Health GH Stock Holding History

MetLife Investment Management’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.26M Buy
67,825
+903
+1% +$90.7K 0.03% 526
2025
Q4 		$6.84M Sell
66,922
-3,135
-4% -$280K 0.03% 487
2025
Q3 		$4.38M Sell
70,057
-1,063
-1% -$57.8K 0.02% 692
2025
Q2 		$3.7M Buy
71,120
+947
+1% +$42.3K 0.02% 700
2025
Q1 		$2.99M Sell
70,173
-1,976
-3% -$85.3K 0.02% 853
2024
Q4 		$2.2M Buy
72,149
+4,002
+6% +$113K 0.01% 985
2024
Q3 		$1.56M Hold
68,147
– – 0.01% 1151
2024
Q2 		$1.97M Buy
68,147
+9,542
+16% +$222K 0.01% 980
2024
Q1 		$1.21M Hold
58,605
– – 0.01% 1197
2023
Q4 		$1.59M Hold
58,605
– – 0.01% 1057
2023
Q3 		$1.74M Hold
58,605
– – 0.01% 966
2023
Q2 		$2.1M Buy
58,605
+52,701
+893% +$1.51M 0.02% 916
2023
Q1 		$138K Buy
5,904
+13
+0.2% +$371 ﹤0.01% 2420
2022
Q4 		$160K Sell
5,891
-155
-3% -$7.09K ﹤0.01% 2381
2022
Q3 		$325K Buy
6,046
+5
+0.1% +$257 ﹤0.01% 1944
2022
Q2 		$244K Buy
6,041
+230
+4% +$11.4K ﹤0.01% 2175
2022
Q1 		$385K Buy
+5,811
New +$398K ﹤0.01% 1943
2020
Q1 		– Sell
-3,147
Closed -$241K – 2266
2019
Q4 		$246K Buy
+3,147
New +$227K ﹤0.01% 1868
2019
Q3 		– Sell
-6,515
Closed -$562K – 2355
2019
Q2 		$562K Hold
6,515
– – 0.01% 1410
2019
Q1 		$500K Sell
6,515
-2,107
-24% -$117K 0.01% 1454
2018
Q4 		$324K Buy
+8,622
New +$318K ﹤0.01% 1626

Other funds holding GH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

MetLife Investment Management's GH Position: Q1 2026 in Review

MetLife Investment Management increased its Guardant Health (GH) stake by 1.3% in Q1 2026, buying an estimated $90.7K and bringing the position to 67,825 shares worth $6.26M. The position accounts for 0.03% of the portfolio, ranked #526.

MetLife Investment Management first reported a position in GH in Q4 2018 and has held it in 21 quarters since. The position peaked at $6.84M in Q4 2025. 481 funds tracked by Wall St. Rank hold GH as of Q1 2026.

  • MetLife Investment Management held 67,825 shares of Guardant Health worth $6.26M as of Q1 2026.
  • MetLife Investment Management bought 903 Guardant Health shares in Q1 2026, an estimated $90.7K.
  • Guardant Health made up 0.03% of MetLife Investment Management's portfolio in Q1 2026, its #526 holding.
  • MetLife Investment Management first reported a position in Guardant Health in Q4 2018 and has held it in 21 quarters since.
  • MetLife Investment Management's Guardant Health position peaked at $6.84M in Q4 2025.
  • 481 funds tracked by Wall St. Rank held Guardant Health as of Q1 2026.

Based on MetLife Investment Management's 13F filing for Q1 2026, filed 14 May 2026.